Recent advances in apheresis have emerged in a variety of clinical settings. Improvements in granulocyte and peripheral blood stem cell collection and mobilization, the changing role of intravenous gamma globulin, the importance of patient assessment and selection of replacement fluids, and the progress in both affinity apheresis and photopheresis are presented. These current trends, their limitation, and their promise in treating a diversity of diseases inspire the future of this technology.